As a federation, it is essential that IFPA’s members’ voices remain at the heart of this process.
The updated IFPA strategy will take us into the next 50 years of the organization. Progress has certainly been made
over the past five decades. The introduction of systemic therapies like biologics has revolutionized treatment for
millions of people living with severe psoriatic disease. Noncommunicable diseases are getting more attention among policymakers than ever before.
Still, there is much work left to be done. Access to treatment must be improved. Comorbidities must be addressed. Psoriatic disease remains a serious global health challenge, with a range of unmet needs.
IFPA’s new vision, mission, and advocacy targets will launch us into the future. Together we will tackle the physical, social, emotional, and economic burdens of psoriasis and psoriatic arthritis. A fully virtual conference this June 30th-3 July will enable more participants to join and learn on the global initiatives and adapt to our region. Look forward to it!